Anti-NRIP1 antibodies are used in the immunodetection of the protein nuclear receptor interacting protein 1. In humans, the canonical protein has a reported length of 1158 amino acid residues and a mass of 126.9 kDa. Its subcellular localization is in the nucleus. It is notably widely expressed in many tissue types. NRIP1 is known to be involved with the metabolism of lipids and the regulation of transcription. Post-translational modifications have been described, including acetylation and phosphorylation. The NRIP1 gene has been associated with the disease, Congenital anomalies of kidney and urinary tract. Synonyms for this target antigen include RIP140, nuclear factor RIP140, receptor-interacting protein 140, and CAKUT3. NRIP1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Some NRIP1 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. In addition, ELISA is also a common application.